Fahrbach K - Search Results

1

Comparative efficacy and safety of systemic therapies used in moderate-to-severe atopic dermatitis: a systematic literature review and network meta-analysis.

Silverberg JI, Thyssen JP, Fahrbach K, Mickle K, Cappelleri JC, Romero W, Cameron MC, Myers DE, Clibborn C, DiBonaventura M. Silverberg JI, et al. Among authors: fahrbach k. J Eur Acad Dermatol Venereol. 2021 Sep;35(9):1797-1810. doi: 10.1111/jdv.17351. Epub 2021 Jun 12. J Eur Acad Dermatol Venereol. 2021. PMID: 33991374 Free PMC article. Review.

2

Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis.

Fahrbach K, Tarpey J, Washington EB, Hughes R, Thom H, Neary MP, Cha A, Gerber R, Cappelleri JC. Fahrbach K, et al. Dermatol Ther (Heidelb). 2020 Aug;10(4):681-694. doi: 10.1007/s13555-020-00389-5. Epub 2020 May 20. Dermatol Ther (Heidelb). 2020. PMID: 32435999 Free PMC article.

3

Correction to: Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systematic Literature Review and Network Meta-Analysis.

Fahrbach K, Tarpey J, Washington EB, Hughes R, Thom H, Neary MP, Cha A, Gerber R, Cappelleri JC. Fahrbach K, et al. Dermatol Ther (Heidelb). 2020 Dec;10(6):1441-1444. doi: 10.1007/s13555-020-00452-1. Dermatol Ther (Heidelb). 2020. PMID: 33025454 Free PMC article.

4

Response to the Letter to the Editor Regarding "Crisaborole Ointment, 2%, for Treatment of Patients with Mild-to-Moderate Atopic Dermatitis: Systemic Literature Review and Network Meta-Analysis".

Fahrbach K, Tarpey J, Washington EB, Hughes R, Thom H, Neary MP, Cha A, Gerber R, Cappelleri JC. Fahrbach K, et al. Dermatol Ther (Heidelb). 2021 Dec;11(6):2241-2244. doi: 10.1007/s13555-021-00608-7. Epub 2021 Oct 10. Dermatol Ther (Heidelb). 2021. PMID: 34628584 Free PMC article. No abstract available.

5

Real-world evidence comparing oral anticoagulants in non-valvular atrial fibrillation: a systematic review and network meta-analysis.

Deitelzweig S, Bergrath E, di Fusco M, Kang A, Savone M, Cappelleri JC, Russ C, Betts M, Cichewicz A, Schaible K, Tarpey J, Fahrbach K. Deitelzweig S, et al. Among authors: fahrbach k. Future Cardiol. 2022 May;18(5):393-405. doi: 10.2217/fca-2021-0120. Epub 2022 Apr 1. Future Cardiol. 2022. PMID: 35360925 Review.

6

Safety and effectiveness of classical and alternative sunitinib dosing schedules for metastatic renal cell carcinoma: a meta-analysis.

Abogunrin S, Ashaye AO, Cappelleri JC, Clair AG, Fahrbach K, Ramaswamy K, Serfass L, Srinivas S, Thomaidou D, Zanotti G. Abogunrin S, et al. Among authors: fahrbach k. Future Oncol. 2019 Jun;15(18):2175-2190. doi: 10.2217/fon-2018-0858. Epub 2019 Apr 23. Future Oncol. 2019. PMID: 31010323

7

A comparative evaluation of gemtuzumab ozogamicin + daunorubicin-cytarabine and other treatments for newly diagnosed acute myeloid leukemia.

Ashaye AO, Khankhel Z, Xu Y, Fahrbach K, Mokgokong R, Orme ME, Lang K, Cappelleri JC, Mamolo C. Ashaye AO, et al. Among authors: fahrbach k. Future Oncol. 2019 Feb;15(6):663-681. doi: 10.2217/fon-2018-0512. Epub 2018 Nov 19. Future Oncol. 2019. PMID: 30450960

8

Indirect Treatment Comparison of Inotuzumab Ozogamicin Versus Blinatumomab for Relapsed or Refractory Acute Lymphoblastic Leukemia.

Proskorovsky I, Su Y, Fahrbach K, Vandendries E, Pagé V, Onyekwere U, Wang Y, Cappelleri JC, Stelljes M. Proskorovsky I, et al. Among authors: fahrbach k. Adv Ther. 2019 Aug;36(8):2147-2160. doi: 10.1007/s12325-019-00991-w. Epub 2019 May 28. Adv Ther. 2019. PMID: 31140123 Free PMC article.

9

Comparative efficacy of non-statin lipid-lowering therapies in patients with hypercholesterolemia at increased cardiovascular risk: a network meta-analysis.

Burnett H, Fahrbach K, Cichewicz A, Jindal R, Tarpey J, Durand A, Di Domenico M, Reichelt A, Viljoen A. Burnett H, et al. Among authors: fahrbach k. Curr Med Res Opin. 2022 May;38(5):777-784. doi: 10.1080/03007995.2022.2049164. Epub 2022 Mar 20. Curr Med Res Opin. 2022. PMID: 35262430

10

Short-Term Efficacy of Biologic Therapies in Moderate-to-Severe Plaque Psoriasis: A Systematic Literature Review and an Enhanced Multinomial Network Meta-Analysis.

Fahrbach K, Sarri G, Phillippo DM, Neupane B, Martel SE, Kiri S, Reich K. Fahrbach K, et al. Dermatol Ther (Heidelb). 2021 Dec;11(6):1965-1998. doi: 10.1007/s13555-021-00602-z. Epub 2021 Sep 22. Dermatol Ther (Heidelb). 2021. PMID: 34549383 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

76 results

Search Page

Filters